Feline infectious peritonitis (FIP), first described in 1963 ([@bib0090]), is a fatal, immune-augmented, and progressive viral disease of cats associated with feline coronavirus (FCoV). Coronaviruses are enveloped positive-strand RNA viruses that infect a wide range of vertebrate species ([@bib0135]). Although FCoV is common in most domestic, feral and non-domestic cat populations world-wide (seroprevalence from 20 to 100%), less than 10% of FCoV seropositive cats develop FIP ([@bib0005], [@bib0010], [@bib0110]). FIP tends to occur most frequently in cats less than two years of age or, less commonly, in geriatric cats ([@bib0070]). The clinical manifestation of FCoV infection can present either as the pathogenic disease manifestation of FIP (FIPV-cases) or the more common, benign or mild enteric infection (FECV-asymptomatic) ([@bib0050], [@bib0170]). Specific genetic determinants of these clinical outcomes have yet to be discovered. There is no effective treatment, vaccine, nor a diagnostic protocol that can discriminate the avirulent FECV from the pathogenic FIPV. Cats infected with FCoV that show no evidence of disease are thought to be carriers of FCoV and may pose an FIP risk to other cats ([@bib0005], [@bib0070], [@bib0075]).

Based on serological differences, FCoV strains have been separated into a common type 1 form (80--90% prevalent in infected cats) and a less common type 2 form ([@bib0170]). FCoV types 1 and 2 appear to utilize distinct cell entry receptors and display different growth characteristics *in vitro*, due to the presence of different *spike* genes ([@bib0060], [@bib0265]). Recent *in vitro* work with chimeric viruses has shown that FCoV serotype 2 (strain 79-1146) and a chimera serotype 1 virus (strain Black), expressing a serotype 2 spike protein, utilize the feline aminopeptidase N (fAPN) cellular receptor. In contrast, serotype 1 FCoVs most likely use an alternate main cellular receptor ([@bib0255]). Further, a feline homologue to human *dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin* (*DC-SIGN*), *fDC-SIGN*, has been identified as a coreceptor in both serotype 1 and 2 infection *in vitro* ([@bib0195]). Both virulent and avirulent FCoV strains are found within types 1 and 2 *in vivo*.

An "*in vivo* mutation transition hypothesis" also called the "internal mutation hypothesis" postulates that *de novo* virus mutation occurs *in vivo* giving rise to viruses that are able to spread systemically and lead to FIP pathogenesis ([@bib0190], [@bib0270]). This hypothesis has been widely accepted for decades and numerous publications have supported this hypothesis ([@bib0005], [@bib0010], [@bib0070], [@bib0075], [@bib0160], [@bib0165], [@bib0175], [@bib0190], [@bib0270]). However, the precise nature of the mutation responsible for pathogenesis has not been identified, although studies have suggested sequence differences in the spike protein ([@bib0220]), membrane protein ([@bib0030]), or *NSP 3c* ([@bib0175]) are involved. Together with *in vitro* studies describing the FIPV strains affinity for macrophages in contrast to FECV strains ([@bib0235]), the hypothesis was extended to propose that the enteric coronavirus (FECV) undergoes a mutational shift in the gastrointestinal system, thus allowing infection of macrophages, systemic dissemination and fatal disease manifestation ([@bib0190], [@bib0270]).

Mutational transition in viral pathogenesis has been shown in HIV infection, where specific amino acid changes in the *envelope* gene determine which coreceptor (CCR5 or CXCR4) is used and hence virus success in cell entry ([@bib0080]). Similarly, key amino acid changes in the spike protein lead to virulence in transmissible gastroenteritis virus (TGEV) ([@bib0025], [@bib0230]), although the exact switch to pathogenesis in TGEV is still unresolved ([@bib0155], [@bib0225]).

The existence of distinct "circulating avirulent and virulent strains" is an alternative and less popular hypothesis of viral pathogenesis. Because FIP occurs sporadically and outbreaks of FIP in domestic cat populations are uncommon, there has been little epidemiologic support for this hypothesis ([@bib0190]). In this hypothesis, both benign and pathogenic strains of a virus circulate in a population, and those individuals exposed to the virulent strains, with the appropriate predisposition, develop disease sequelae. Dengue hemorrhagic fever is an example of this, as four viral strains circulate worldwide and individuals exposed for a second time to a virus of a different strain, mount an inappropriate immune response and exhibit pathology consistent with immune-mediated vasculitis ([@bib0140]). The zoonotic equine venezuelan encephalitis virus is another example as virulent and avirulent strains of the alphavirus have both been shown to circulate and ecological and epidemiological factors have been identified that contribute or constrain the frequency of disease sequela in equids and humans ([@bib0020]). Recent viral sequence analyses of FCoVs from 56 shelter cats in Maryland suggest that there can be circulating strains of virulent and avirulent FCoVs ([@bib0030]). Viral dynamics from both the *in vivo* mutation hypothesis and the circulating virulent and avirulent strain hypotheses may play a role in the complex pathogenesis of FIP. Certain circulating strains may be predisposed to *in vivo* mutation in an, as of yet, unidentified locus. Alternatively, virulent strains may in some cases be distinctive from avirulent strains in outbreaks of FIP, as shown in a Maryland phylogenetic study of barn cats ([@bib0030]).

Since the outbreak of the severe acute respiratory syndrome (SARS) in 2003 a new highly pathogenic coronavirus, SARS-CoV, has been identified and many coronavirus genomes have been sequenced. GenBank now reports the full-length sequence of over twenty types of coronavirus, including 45 full-length sequences of FCoV and 2 annotated full-length sequences ([@bib0060], [@bib0065]). Coronaviruses are a large family of enveloped, single strand, positive sense, non-segmented RNA viruses. Approximately 30 kilobases in length, coronaviruses have the largest viral RNA genomes known ([@bib0210]). The first 2/3 of the coronavirus genome encodes the replicase genes: open reading frames (ORFs) 1a and 1b. Proteolytic processing of these polyproteins, mediated by viral cysteine proteinases, produce non-structural proteins (NSPs), some of which are responsible for replicating the viral genome and/or generating a nested set of subgenomic mRNAs to express all of the other ORFs in the genome ([@bib0260], [@bib0285]). The ORFs for the structural proteins, spike, envelope, membrane and nucleocapsid, are encoded in the remaining portion of the genome. Coronaviruses may encode different numbers of *NSPs*, and the predicted sequences of these proteins do not share high level of homology ([@bib0220]).

Viral genetic determinants specifically associated with FIPV pathogenesis have not yet been discovered and are currently an area of intense research. Viral gene signatures in the *spike* ([@bib0205], [@bib0220]), *NSP 3c* ([@bib0040], [@bib0160]), and *membrane* ([@bib0030]) of the coronavirus genome have been shown to often correlate with disease manifestation.

The *spike* gene encodes a large glycoprotein, which forms spikes on virion surfaces, binds to specific cellular receptors, induces neutralizing antibody, and elicits cell-mediated immunity ([@bib0220]). Spike has been implicated as a determinant of virulence in TGEV ([@bib0025], [@bib0230]), and neurological murine hepatitis virus ([@bib0185]), but not in FCoV, SARS, or infectious bronchitis virus ([@bib0250]). Studies directed at the spike gene have been further complicated because previous work focused on serotype II isolates (79-1146 and 79-1683) which can be grown in cell culture and encodes a *spike* gene of canine origin, rather than the more prevalent serotype I ([@bib0085], [@bib0160]). Amino acid differences were detected in the spike of FIPV isolate 79-1146 vs. FECV 79-1683, although additional study of different FCoV serotype I isolates did not exhibit similar genetic changes ([@bib0220]). However, more recent *in vitro* studies of cathepsin B and cathepsin L activity in different isolates of FCoV showed that FECV isolates were able to induce a specific cleavage event in the spike protein in contrast to FIPV isolates, suggesting that cathepsin activity on the spike gene may play a role in viral pathogenesis at the level of cell entry ([@bib0200]).

*NSPs* are involved with virulence in SARS ([@bib0015], [@bib0250]). Recently, the role of *NSP 1* has been documented in coronavirus virulence ([@bib0105]). Among the coronavirus family, the SARS-CoV genome encodes the largest number of NSPs (eight) while human HCoV-229E, pig (TGEV), bird (IBV), mouse (MHV), and cat (FCoV) encode two, two, four, two, and five, respectively. In FCoV, *NSP 3c* has been implicated in FIP pathogenesis ([@bib0270]). Phylogenetic study of the *NSP 7b* and *3c* genes in a small group of cats exposed to FCoV, found relatedness a consequence of geographic locale, rather than clinical disease outcome ([@bib0270]). Recent work by [@bib0040] analyzed the *3c* gene in natural isolates from 27 FECV- and 28 FIPV-infected cats. They found intact *3c* genes in all FECVs, while the majority of FIPVs (71.4%) had disrupted *3c* genes. Further, most cats with FIP had no detectable intestinal coronavirus. Their findings suggested that *3c*-inactivated viruses only rarely replicate in the gut, which possibly explains the rare incidence of FIP outbreaks. Similarly, [@bib0175] studied single nucleotide polymorphisms and deletions causing truncation of the *3c* gene product in virus isolates from FIPV and FECV isolates from two geographic locations. They also found that most, but not all, coronaviruses sequenced from fecal isolates had intact *3c* genes while almost all isolates from the diseased tissues of FIP cases had disrupted *3c* genes.

The membrane protein is the most abundant structural protein, with important functions in virus budding ([@bib0215]). The membrane protein also interacts with cell-mediated host immunity ([@bib0215]), and is known to both induce alpha interferon ([@bib0125]) and induce apoptosis ([@bib0035], [@bib0280]). Recent studies of the *membrane* gene ([@bib0030]) in 56 free-ranging domestic cat isolates from Maryland demonstrated distinct viral genotypes highly correlated with disease phenotype.

Epidemiologic data suggests that the cat\'s genetic background contributes to the manifestation of FIP. Indeed, variation in breed susceptibility and/or resistance to FIP has been noted by investigators ([@bib0145], [@bib0180]), and outbreaks of FIP in captive cheetah populations, known for their lack of genetic diversity, is suggestive of a role of host genetics in FIP disease pathogenesis ([@bib0150]). Host genetic background has been shown to alter the pathogenesis of viral pathogens relating to inappropriate immune responses (e.g. HIV and Dengue virus), susceptibility to infection (*CCR5* in HIV AIDS), and the development of clinical symptoms (*CCR5*, *CCR2*, *SDF1*, *RANTES* in *HIV AIDS*) ([@bib0095]). Studies of cats with FIP have shown that cytokine expressions are altered as compared to healthy cats ([@bib0055], [@bib0120]). Specifically, expression of interleukin (IL)-1 beta and interleukin-6 are significantly increased in cats with FIP, likely produced by infected macrophages and monocytes ([@bib0120], [@bib0240], [@bib0245]). It has been shown that tumor necrosis factor (TNF)-alpha is able to induce feline T-cell apoptosis, making it the most likely causative agent of T-cell lymphopenia in FIPV-infected cats ([@bib0055], [@bib0240]). Candidate genes such as *IL-12*, *IL-10*, *IL-6* ([@bib0115]), *interferon (IFN)-gamma*, *TNF-alpha* ([@bib0045]), *liver/lymph node specific intracellular adhesion molecules-3 grabbing non-integrin* (*L-SIGN*) ([@bib0100]), *DC-SIGN* ([@bib0200], [@bib0275]), *angiotensin-converting enzyme* (*Ace2*) ([@bib0130]), and *fAPN* ([@bib0265]) have been identified as associated with coronavirus disease findings in cat, mouse, and human cases.

Further studies exploring both viral and host genetic determinants of disease in FIP offer specific opportunities for the management of this disease. To date, these studies have unfortunately been limited in the geographic and temporal diversity of the isolates studied. If additional studies are conducted in additional cat populations, the development of antemortem screening tools for genetic disposition for disease as well as the discrimination of virulent versus avirulent strains of FCoV may be possible.
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